Clinical Trials Browser

NCT07405086 2026-05-22

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis

Clinical Trials

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

PROMETHEE

Dabrafenib and/or Trametinib Rollover Study

GASTIVA

Erector Spinae Block for Thoracic Surgery

FROSTBITE-3

CP-MINS

Postoperative Radiotherapy for Postoperative N2 Metastases of NSCLC in the Immunotherapy Era (Phase II)

Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan

CROWD

Lung Nodule Detection Using Ultra-long FOV PET/CT

OSIBOOST 2

Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer

ADAPT ALEC

The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action

The Effects of Using Different Anesthetics on the Prognosis of Primary Lung Tumors and Its Mechanism of Action

Opioid Free Anaesthesia-Analgesia Strategy on Surgical Stress and Immunomodulation in Elective VATS-Lobectomy for NSCLC